This activity has been designed to inform oncologists who manage patients with mCRC how to safely and effectively incorporate dose optimization strategies and sequencing into current clinical algorithms, and features a roundtable discussion of renowned clinical experts, Drs. Axel Grothey, Eric Van Cutsem, and Tanios S. Bekaii-Saab, on the latest advances and insights from pivotal clinical trials.
Earn CME Credit for this activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=CRC
© 2018 Imedex, LLC.